Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury

Adams, 1984, Diffuse axonal injury in head injuries caused by a fall, Lancet, 2, 1420, 10.1016/S0140-6736(84)91620-9 Baba, 1998, Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies, Am. J. Pathol., 152, 879 Ballarin, 2018, Discovery and development of NA-1 for the treatment of acute ischemic stroke, Acta Pharm. Sin., 39, 661, 10.1038/aps.2018.5 Bheda, 2010, Ubiquitin editing enzyme UCH L1 and microtubule dynamics: implication in mitosis, Cell Cycle (Georgetown, Tex), 9, 980, 10.4161/cc.9.5.10934 Bilguvar, 2013, Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration, Proc. Natl. Acad. Sci. USA, 110, 3489, 10.1073/pnas.1222732110 Bishop, 2014, The ubiquitin C-terminal hydrolase L1 (UCH-L1) C terminus plays a key role in protein stability, but its farnesylation is not required for membrane association in primary neurons, J. Biol. Chem., 289, 36140, 10.1074/jbc.M114.557124 Blokhuis, 2013, Protein aggregation in amyotrophic lateral sclerosis, Acta Neuropathol., 125, 777, 10.1007/s00401-013-1125-6 Bonet-Costa, 2016, The proteasome and oxidative stress in Alzheimer's disease, Antioxid. Redox Signal, 25, 886, 10.1089/ars.2016.6802 Boudreaux, 2010, Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation, Proc Natl Acad Sci U S A, 107, 9117, 10.1073/pnas.0910870107 Bremm, 2011, Emerging roles for Lys11-linked polyubiquitin in cellular regulation, Trends Biochem Sci., 36, 355 Cao, 2002, In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis, J. Neurosci., 22, 5423, 10.1523/JNEUROSCI.22-13-05423.2002 Carmine Belin, 2007, S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden, Park. Relat. Disord., 13, 295, 10.1016/j.parkreldis.2006.12.002 Castegna, 2004, Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl-terminal hydrolase L-1, reveals oxidation of key proteins, J. Neurochem, 88, 1540, 10.1046/j.1471-4159.2003.02288.x Castegna, 2002, Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1, Free Radic. Biol. Med, 33, 562, 10.1016/S0891-5849(02)00914-0 Chamorro, 2016, Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation, Lancet Neurol., 15, 869, 10.1016/S1474-4422(16)00114-9 Chen, 2010, Ubiquitin carboxyl-terminal hydrolase L1 is required for maintaining the structure and function of the neuromuscular junction, Proc. Natl. Acad. Sci. USA, 107, 1636, 10.1073/pnas.0911516107 Chen, 2020, Therapeutic targets of oxidative/nitrosative stress and neuroinflammation in ischemic stroke: Applications for natural product efficacy with omics and systemic biology, Pharm. Res, 158, 10.1016/j.phrs.2020.104877 Chen, 2019, Ubiquitin-mediated regulation of autophagy, J. Biomed. Sci., 26, 80, 10.1186/s12929-019-0569-y Choi, 2004, Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases, J. Biol. Chem., 279, 13256, 10.1074/jbc.M314124200 Ciechanover, 2015, Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies, Exp. Mol. Med, 47, 10.1038/emm.2014.117 Clarke, 2004, Fighting cancer by disrupting C-terminal methylation of signaling proteins, J. Clin. Invest., 113, 513, 10.1172/JCI200421059 Collins, 2017, The Logic of the 26S Proteasome, Cell, 169, 792, 10.1016/j.cell.2017.04.023 Coulombe, 2014, Loss of UCHL1 promotes age-related degenerative changes in the enteric nervous system, Front. Aging Neurosci., 6, 129, 10.3389/fnagi.2014.00129 Das, 2006, Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1, Proc. Natl. Acad. Sci. USA, 103, 4675, 10.1073/pnas.0510403103 Day, 2010, UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein, Prog. Neurobiol., 90, 327, 10.1016/j.pneurobio.2009.10.020 Ding, 2008, Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome, Autophagy, 4, 141, 10.4161/auto.5190 Doyle, 2011, Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders, J. Cell Mol. Med., 15, 2025, 10.1111/j.1582-4934.2011.01374.x Edwards, 2020, Traumatic brain injury induces tau aggregation and spreading, J. Neurotrauma, 37, 80, 10.1089/neu.2018.6348 Erpapazoglou, 2014, Versatile roles of k63-linked ubiquitin chains in trafficking, Cells, 3, 1027, 10.3390/cells3041027 Esler, 2001, A portrait of Alzheimer secretases--new features and familiar faces, Science, 293, 1449, 10.1126/science.1064638 Frati, 2017, Diffuse axonal injury and oxidative stress: a comprehensive review, Int J. Mol. Sci., 18 Genc, 2022, Upper motor neurons are a target for gene therapy and UCHL1 is necessary and sufficient to improve cellular integrity of diseased upper motor neurons, Gene Ther., 29, 178, 10.1038/s41434-021-00303-4 Genc, 2016, Absence of UCHL 1 function leads to selective motor neuropathy, Ann. Clin. Transl. Neurol., 3, 331, 10.1002/acn3.298 Glickman, 2002, The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction, Physiol. Rev., 82, 373, 10.1152/physrev.00027.2001 Gong, 2006, Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory, Cell, 126, 775, 10.1016/j.cell.2006.06.046 Goto, 2015, UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1alpha, Nat. Commun., 6, 6153, 10.1038/ncomms7153 Grimm, 2011, Protein oxidative modifications in the ageing brain: consequence for the onset of neurodegenerative disease, Free Radic. Res, 45, 73, 10.3109/10715762.2010.512040 Guglielmotto, 2017, The decrease of Uch-L1 activity is a common mechanism responsible for abeta 42 accumulation in Alzheimer's and vascular disease, Front Aging Neurosci., 9, 320, 10.3389/fnagi.2017.00320 Guglielmotto, 2019, Stroke and amyloid-beta downregulate TREM-2 and Uch-L1 expression that synergistically promote the inflammatory response, J. Alzheimers Dis., 71, 907, 10.3233/JAD-190494 Guo, 2017, Ubiquitin C-terminal hydrolase L1 (UCH-L1) promotes hippocampus-dependent memory via its deubiquitinating effect on TrkB, J. Neurosci., 37, 5978, 10.1523/JNEUROSCI.3148-16.2017 Hill, 2012, Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial, Lancet Neurol., 11, 942, 10.1016/S1474-4422(12)70225-9 Hinman, 2014, The back and forth of axonal injury and repair after stroke, Curr. Opin. Neurol., 27, 615, 10.1097/WCO.0000000000000149 Hu, 2000, Protein aggregation after transient cerebral ischemia, J. Neurosci., 20, 3191, 10.1523/JNEUROSCI.20-09-03191.2000 Hurst-Kennedy, 2012, Ubiquitin C-terminal hydrolase l1 in tumorigenesis, Biochem. Res. Int., 2012, 10.1155/2012/123706 Ichihara, 1995, Axonal degeneration promotes abnormal accumulation of amyloid beta-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse, Brain Res., 695, 173, 10.1016/0006-8993(95)00729-A Ichikawa, 2010, Ubiquitin carboxyl terminal hydrolase L1 negatively regulates TNFalpha-mediated vascular smooth muscle cell proliferation via suppressing ERK activation, Biochem. Biophys. Res. Commun., 391, 852, 10.1016/j.bbrc.2009.11.151 Jara, 2013, Could dysregulation of UPS be a common underlying mechanism for cancer and neurodegeneration? Lessons from UCHL1, Cell Biochem. Biophys., 67, 45, 10.1007/s12013-013-9631-7 Jara, 2015, Corticospinal motor neurons are susceptible to increased ER stress and display profound degeneration in the absence of UCHL1 function, Cereb. Cortex, 25, 4259, 10.1093/cercor/bhu318 Kabuta, 2008, Insights into links between familial and sporadic Parkinson's disease: physical relationship between UCH-L1 variants and chaperone-mediated autophagy, Autophagy, 4, 827, 10.4161/auto.6560 Kabuta, 2008, Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy, J. Biol. Chem., 283, 23731, 10.1074/jbc.M801918200 Kabuta, 2008, Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1, Hum. Mol. Genet, 17, 1482, 10.1093/hmg/ddn037 Kalaria, 2016, Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease, Acta Neuropathol., 131, 659, 10.1007/s00401-016-1571-z Kang, 1987, The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor, Nature, 325, 733, 10.1038/325733a0 Kemp, 2016, Recent advances in the discovery of deubiquitinating enzyme inhibitors, Prog. Med. Chem., 55, 149, 10.1016/bs.pmch.2015.10.002 Kikuchi, 1990, Axonal degeneration of ascending sensory neurons in gracile axonal dystrophy mutant mouse, Acta Neuropathol., 80, 145, 10.1007/BF00308917 Kim, 2014, N-terminal truncated UCH-L1 prevents Parkinson's disease associated damage, PloS One, 9 Kim, 2011, Systematic and quantitative assessment of the ubiquitin-modified proteome, Mol. Cell, 44, 325, 10.1016/j.molcel.2011.08.025 Kinney, 2018, Inflammation as a central mechanism in Alzheimer's disease, Alzheimers Dement (N.Y.), 4, 575, 10.1016/j.trci.2018.06.014 Koharudin, 2010, Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1, Proc. Natl. Acad. Sci. USA, 107, 6835, 10.1073/pnas.1002295107 Komander, 2009, Breaking the chains: structure and function of the deubiquitinases, Nat. Rev. Mol. Cell Biol., 10, 550, 10.1038/nrm2731 Komander, 2009, Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains, EMBO Rep., 10, 466, 10.1038/embor.2009.55 Kopito, 2000, Aggresomes, inclusion bodies and protein aggregation, Trends Cell Biol., 10, 524, 10.1016/S0962-8924(00)01852-3 Kozlov, 2017, Alterations in nitric oxide homeostasis during traumatic brain injury, Biochim. Biophys. Acta Mol. Basis Dis., 1863, 2627, 10.1016/j.bbadis.2016.12.020 Kumar, 2017, S-nitrosylation of UCHL1 induces its structural instability and promotes alpha-synuclein aggregation, Sci. Rep., 7, 44558, 10.1038/srep44558 Kunz, 2009, Cerebral vascular dysregulation in the ischemic brain, Handb. Clin. Neurol., 92, 283, 10.1016/S0072-9752(08)01914-3 Kwon, 2017, The ubiquitin code in the ubiquitin-proteasome system and autophagy, Trends Biochem Sci., 42, 873, 10.1016/j.tibs.2017.09.002 Lange, 2022, Deubiquitinases: from mechanisms to their inhibition by small molecules, Mol. Cell, 82, 15, 10.1016/j.molcel.2021.10.027 Larsen, 1996, Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues, Biochemistry, 35, 6735, 10.1021/bi960099f Larsen, 1998, Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases, Biochemistry, 37, 3358, 10.1021/bi972274d Lee, 2017, Familial mutations and post-translational modifications of UCH-L1 in Parkinson's disease and neurodegenerative disorders, Curr. Protein Pept. Sci., 18, 733, 10.2174/1389203717666160217143721 Leroy, 1998, The ubiquitin pathway in Parkinson's disease, Nature, 395, 451, 10.1038/26652 Li, 2020, UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis, Ann. Clin. Transl. Neurol., 7, 1420, 10.1002/acn3.51141 Liu, 2017, In vivo transduction of neurons with TAT-UCH-L1 protects brain against controlled cortical impact injury, PloS One, 12 Liu, 2011, Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury, Neurobiol. Dis., 41, 318, 10.1016/j.nbd.2010.09.020 Liu, 2015, The point mutation UCH-L1 C152A protects primary neurons against cyclopentenone prostaglandin-induced cytotoxicity: implications for post-ischemic neuronal injury, Cell Death Dis., 6, 10.1038/cddis.2015.323 Liu, 2013, Increased generation of cyclopentenone prostaglandins after brain ischemia and their role in aggregation of ubiquitinated proteins in neurons, Neurotox. Res, 24, 191, 10.1007/s12640-013-9377-4 Liu, 2019, Role of UCHL1 in axonal injury and functional recovery after cerebral ischemia, Proc. Natl. Acad. Sci. USA Liu, 2002, The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility, Cell, 111, 209, 10.1016/S0092-8674(02)01012-7 Liu, 2021, Peripherally misfolded proteins exacerbate ischemic stroke-induced neuroinflammation and brain injury, J. Neuroinflamm., 18, 29, 10.1186/s12974-021-02081-7 Liu, 2009, Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease, Proc. Natl. Acad. Sci. USA, 106, 4635, 10.1073/pnas.0806474106 Livneh, 2017, Monoubiquitination joins polyubiquitination as an esteemed proteasomal targeting signal, Bioessays, 39 Lowe, 1990, Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases, J. Pathol., 161, 153, 10.1002/path.1711610210 Ma, 2017, Proteasome-independent polyubiquitin linkage regulates synapse scaffolding, efficacy, and plasticity, Proc. Natl. Acad. Sci. USA, 114, E8760, 10.1073/pnas.1620153114 Maraganore, 1999, Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease, Neurology, 53, 1858, 10.1212/WNL.53.8.1858 Masters, 1985, Amyloid plaque core protein in Alzheimer disease and Down syndrome, Proc. Natl. Acad. Sci. USA, 82, 4245, 10.1073/pnas.82.12.4245 Mejzini, 2019, ALS genetics, mechanisms, and therapeutics: where are we now?, Front. Neurosci., 13, 1310, 10.3389/fnins.2019.01310 Mellick, 2000, The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease, Neurosci. Lett., 293, 127, 10.1016/S0304-3940(00)01510-X Mi, 2021, Mutation of a ubiquitin carboxy terminal hydrolase L1 lipid binding site alleviates cell death, axonal injury, and behavioral deficits after traumatic brain injury in mice, Neuroscience, 475, 127, 10.1016/j.neuroscience.2021.09.001 Mi, 2021, Abolishing UCHL1's hydrolase activity exacerbates TBI-induced axonal injury and neuronal death in mice, Exp. Neurol., 336, 10.1016/j.expneurol.2020.113524 Miyake, 2012, UCHL1 S18Y variant is a risk factor for Parkinson's disease in Japan, BMC Neurol., 12, 62, 10.1186/1471-2377-12-62 Mukoyama, 1989, Neuropathology of gracile axonal dystrophy (GAD) mouse. An animal model of central distal axonopathy in primary sensory neurons, Acta Neuropathol., 79, 294, 10.1007/BF00294664 Nagamine, 2010, Deficiency of ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1) leads to vulnerability to lipid peroxidation, Neurochem Int, 57, 102, 10.1016/j.neuint.2010.04.015 Nakamura, 2021, Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease, Science, 371 Nakao, 2018, High expression of ubiquitin C-terminal hydrolase L1 is associated with poor prognosis in endometrial cancer patients, Int J. Gynecol. Cancer, 28, 675, 10.1097/IGC.0000000000001201 Nakashima, 2017, UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization, Sci. Rep., 7, 6879, 10.1038/s41598-017-06605-1 Nawaz, 2020, Molecular evolutionary and structural analysis of human UCHL1 gene demonstrates the relevant role of intragenic epistasis in Parkinson's disease and other neurological disorders, BMC Evol. Biol., 20, 130, 10.1186/s12862-020-01684-7 Nedelsky, 2008, Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection, Biochim. Biophys. Acta, 1782, 691, 10.1016/j.bbadis.2008.10.002 Nishikawa, 2003, Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants, Biochem. Biophys. Res. Commun., 304, 176, 10.1016/S0006-291X(03)00555-2 Ohtake, 2016, The K48-K63 branched ubiquitin chain regulates NF-kappaB signaling, Mol. Cell, 64, 251, 10.1016/j.molcel.2016.09.014 Osaka, 2003, Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron, Hum. Mol. Genet, 12, 1945, 10.1093/hmg/ddg211 Papa, 2019, Evaluating glial and neuronal blood biomarkers GFAP and UCH-L1 as gradients of brain injury in concussive, subconcussive and non-concussive trauma: a prospective cohort study, BMJ Paediatr. Open, 3, 10.1136/bmjpo-2019-000473 Papa, 2016, Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury, JAMA Neurol., 73, 551, 10.1001/jamaneurol.2016.0039 Rahighi, 2009, Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation, Cell, 136, 1098, 10.1016/j.cell.2009.03.007 Reinicke, 2019, Ubiquitin C-terminal hydrolase L1 (UCH-L1) loss causes neurodegeneration by altering protein turnover in the first postnatal weeks, Proc. Natl. Acad. Sci. USA, 116, 7963, 10.1073/pnas.1812413116 Reiss, 2020, Releasing the lockdown: an emerging role for the ubiquitin-proteasome system in the breakdown of transient protein inclusions, Biomolecules, 10 Ross, 2004, Protein aggregation and neurodegenerative disease, Nat. Med., 10, S10, 10.1038/nm1066 Rydning, 2017, Novel UCHL1 mutations reveal new insights into ubiquitin processing, Hum. Mol. Genet., 26, 1217, 10.1093/hmg/ddx072 Saigoh, 1999, Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice, Nat. Genet., 23, 47, 10.1038/12647 Selkoe, 2001, Alzheimer's disease: genes, proteins, and therapy, Physiol. Rev., 81, 741, 10.1152/physrev.2001.81.2.741 Setsuie, 2007, The functions of UCH-L1 and its relation to neurodegenerative diseases, Neurochem Int, 51, 105, 10.1016/j.neuint.2007.05.007 Setsuie, 2007, Dopaminergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant, Neurochem. Int., 50, 119, 10.1016/j.neuint.2006.07.015 Shen, 2006, Oxidative stress regulated expression of ubiquitin Carboxyl-terminal Hydrolase-L1: role in cell survival, Apoptosis, 11, 1049, 10.1007/s10495-006-6303-8 Singh, 2019, Oxidative stress: a key modulator in neurodegenerative diseases, Molecules, 24 Smith, 2003, Amyloid beta accumulation in axons after traumatic brain injury in humans, J. Neurosurg., 98, 1072, 10.3171/jns.2003.98.5.1072 Soto, 2008, Protein misfolding and neurodegeneration, Arch. Neurol., 65, 184, 10.1001/archneurol.2007.56 Sultana, 2006, Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD, Neurobiol. Aging, 27, 1564, 10.1016/j.neurobiolaging.2005.09.021 Sung, 1980, Axonal dystrophy in the gracile nucleus in congenital biliary atresia and cystic fibrosis (mucoviscidosis): beneficial effect of vitamin E therapy, J. Neuropathol. Exp. Neurol., 39, 584, 10.1097/00005072-198009000-00007 Sweeney, 2017, Protein misfolding in neurodegenerative diseases: implications and strategies, Transl. Neurodegener., 6, 6, 10.1186/s40035-017-0077-5 Szklarczyk, 2017, The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible, Nucleic Acids Res., 45, D362, 10.1093/nar/gkw937 Tabira, 2002, Significance of intracellular Abeta42 accumulation in Alzheimer's disease, Front. Biosci., 7, a44 Taylor, 2003, Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein, Hum. Mol. Genet, 12, 749, 10.1093/hmg/ddg074 Toyama, 2015, S-Mercuration of ubiquitin carboxyl-terminal hydrolase L1 through Cys152 by methylmercury causes inhibition of its catalytic activity and reduction of monoubiquitin levels in SH-SY5Y cells, J. Toxicol. Sci., 40, 887, 10.2131/jts.40.887 Tramutola, 2016, It is all about (U)biquitin: role of altered ubiquitin-proteasome system and UCHL1 in Alzheimer disease, Oxid. Med. Cell Longev., 2016, 2756068, 10.1155/2016/2756068 Walters, 2008, Differential effects of Usp14 and Uch-L1 on the ubiquitin proteasome system and synaptic activity, Mol. Cell Neurosci., 39, 539, 10.1016/j.mcn.2008.07.028 Wang, 2017, Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries, Expert Opin. Ther. Targets, 21, 627, 10.1080/14728222.2017.1321635 Wang, 2021, Thorough overview of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury, Acute Med. Surg., 8, 10.1002/ams2.622 Watts, 2018, Brain energy and oxygen metabolism: emerging role in normal function and disease, Front. Mol. Neurosci., 11, 216, 10.3389/fnmol.2018.00216 Wiborg, 1985, The human ubiquitin multigene family: some genes contain multiple directly repeated ubiquitin coding sequences, EMBO J., 4, 755, 10.1002/j.1460-2075.1985.tb03693.x Wickliffe, 2011, K11-linked ubiquitin chains as novel regulators of cell division, Trends Cell Biol., 21, 656, 10.1016/j.tcb.2011.08.008 Wilkinson, 1992, Comparisons of neuronal (PGP 9.5) and non-neuronal ubiquitin C-terminal hydrolases, Biochem. Soc. Trans., 20, 631, 10.1042/bst0200631 Wilson, 1988, The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies, Br. J. Exp. Pathol., 69, 91 Yamazaki, 1988, Gracile axonal dystrophy (GAD), a new neurological mutant in the mouse, Proc. Soc. Exp. Biol. Med, 187, 209, 10.3181/00379727-187-42656 Yamazaki, 1992, Behavioral study on the gracile axonal dystrophy (GAD) mutant mouse, Jikken Dobutsu, 41, 523 Yu, 2018, UCH-L1 inhibition suppresses tau aggresome formation during proteasomal impairment, Mol. Neurobiol., 55, 3812 Yuan, 2014, K33-linked polyubiquitination of coronin 7 by Cul3-KLHL20 ubiquitin E3 ligase regulates protein trafficking, Mol. Cell, 54, 586, 10.1016/j.molcel.2014.03.035 Zhang, 2014, Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo, Sci. Rep., 4, 7298, 10.1038/srep07298 Zhang, 2012, Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1, J. Neurochem., 120, 1129, 10.1111/j.1471-4159.2011.07644.x